James Raftery: Avastin, Lucentis, and NICE

A useful update was provided at a meeting this week sponsored by the Royal National Institute for the Blind (RNIB) and Patients Involved in NICE (the National Institute for Health and Clinical Excellence). As the proceedings are to be written up and published, I focus here on the key points that emerged for me. […]

Read More…

Julian Sheather on top-up payments

Every so often a story comes along that unexpectedly sheds light on a far more widely shared unease. Top-up payments is one of those stories. For many years we have lived, more or less happily, with a simultaneous headline commitment to an NHS that is free to all on the basis of need, an implicit […]

Read More…